Future supply of new COVID-19 vaccines confirmed
A vaccine to combat the newer strains of COVID-19 has been approved and will be available to New Zealanders in time for winter 2024
Stay updated with breaking news from Medsafe Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A vaccine to combat the newer strains of COVID-19 has been approved and will be available to New Zealanders in time for winter 2024
A vaccine to combat the newer strains of COVID-19 has been approved and will be available to New Zealanders in time for winter 2024.
TheIndiaNewZealandPharmaBusinessMeet,hostedbytheIndianHighCommissioninWellingtononFebruary10,providedaforumforpharmaceuticalcompaniesfromIndiatoengageinbusinesstobusiness(B2B)meetingswiththeirKiwicounterparts.
Nuvaxovid is the fourth Covid-19 vaccine to gain provisional approval from New Zealand's medicines regulator.
Ronapreve is approved for the treatment of COVID-19 for people who are badly affected